Drawing for THE PHARMACEUTICAL LIMS COMPANY

USPTO serial 78212026

THE PHARMACEUTICAL LIMS COMPANY

Reviewed by CopyMark Law Group

Status 601
Filing date
Status date
Registration date
—
Examiner
REGAN, JOHN B
Law office
FILE REPOSITORY (FRANCONIA)

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with THE PHARMACEUTICAL LIMS COMPANY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Timothy D. Pecsenye, Esquire

TIMOTHY D PECSENYE ESQ BLANK ROME LLPONE LOGAN SQ 9TH FLPHILADELPHIA PA, 19103U.S. ARMY

Goods and services

ClassDescriptionStatusFirst use
009COMPUTER SOFTWARE FOR USE IN LABORATORY INFORMATION MANAGEMENT, NAMELY, SOFTWARE USED IN ANALYZING, REPORTING, AND TRACKING PHARMACEUTICAL DRUG STUDY SAMPLES FOR REGULATORY COMPLIANCE; COMPUTER SOFTWARE FOR USE IN LABORATORY INFORMATION MANAGEMENT, NAMELY FOR THE DESIGN, CONDUCTING, INSTRUMENT INTERFACING, DATA ANALYSIS AND REPORTING OF IN VITRO EXPERIMENTS IN THE PHARMACEUTICAL INDUSTRY; COMPUTER SOFTWARE FOR USE IN LABORATORY INFORMATION MANAGEMENT, NAMELY FOR ANALYTICAL DEVELOPMENT AND QUALITY CONTROL IN THE PHARMACEUTICAL INDUSTRY; COMPUTER SOFTWARE PLATFORMS USED FOR LABORATORY INFORMATION MANAGEMENT SYSTEMS IN THE PHARMACEUTICAL INDUSTRY; SCALABLE COMPUTER SOFTWARE FOR USE BY BUSINESS AND INDUSTRY IN RESEARCH AND DEVELOPMENT, NAMELY, SOFTWARE FOR LABORATORY AUTOMATION, GOVERNMENTAL REGULATION COMPLIANCE, WORKFLOW MANAGEMENT AND EVENT NOTIFICATION; COMBINATION COMPUTER SOFTWARE AND COMPUTER-MEDIA- RECORDED ELECTRONIC DATABASE SYSTEM FOR USE IN DRUG DEVELOPMENT PROCESS, NAMELY IN RESEARCH, IN DATA ANALYSIS, IN DATA MANAGEMENT, IN DATA REPORTING, IN SIMULATION AND IN REGULATORY COMPLIANCE FOR DRUG DEVELOPMENTSACTIVE—
016COMPUTER MANUALS AND PRINTED INSTRUCTIONAL, EDUCATIONAL, AND TEACHING MATERIALS FOR SOFTWARE USED IN THE DRUG DEVELOPMENT PROCESSACTIVE—
035LICENSING OF COMPUTER SOFTWARE; BUSINESS CONSULTATION, NAMELY, COMPUTER SOFTWARE TECHNOLOGY CONSULTING SERVICESACTIVE—
042DEVELOPMENT, MAINTENANCE AND UP-DATING OF COMPUTER SOFTWARE FOR USE IN DRUG DEVELOPMENT PROCESS FOR OTHERS; TECHNICAL SUPPORT SERVICES, NAMELY, PROBLEM SOLVING AND TROUBLE-SHOOTING COMPUTER SOFTWARE PROBLEMS; TECHNICAL CONSULTATION, NAMELY, COMPUTER SOFTWARE TECHNOLOGY CONSULTING SERVICESACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 14, 2004ABN1ABANDONMENT - EXPRESS MAILED—
May 24, 2004CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 24, 2004CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 24, 2004MAILPAPER RECEIVED—
Dec 18, 2003GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Nov 6, 2003CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 6, 2003MAILPAPER RECEIVED—
May 4, 2003GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 4, 2003DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance